Mr. Speaker, I listened attentively to the member's remarks. He seemed to be indicating favour and caution at the same time, and there is nothing wrong with that. We want to ensure that we make things better and never worse.
Where I have some difficulty, though, is where the hon. member expresses that he is of the opinion that we do not quite know the effects of things perhaps untested, and I am paraphrasing here and those were not exactly his words. However, given that Scandinavian countries are already doing a lot of this, surely we are talking about things that are at least in some regard tested. This is the first issue I want to raise with the hon. member.
My second issue is that I recognize, and I do not know if we want to call it micro amounts, that trace amounts occur naturally. If I remember the testimony before our committee, and I see the hon. member from Winnipeg is here, I think he will recall, as I do, that those trace amounts that occur naturally do not, and for reasons that I do not understand, produce the same side effects. In other words, they do not seem to produce the toxicity, if I can refer to it that way, as the product that we make into a trans fatty acid artificially, if that is the correct word for it. So there is that difference. I think that has been provided to us in testimony before.